Newron Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.19	6.93	6.34	13.42	25.02
Short-Term Investments	16.69	2.89	6.26	9.35	9.58
Cash & Short-Term Investments	28.88	9.83	12.6	22.77	34.59
Cash Growth	193.87%	-22.01%	-44.68%	-34.17%	10.70%
Accounts Receivable	2.54	42.12	2.02	1.94	1.31
Other Receivables	3.62	4.94	3.16	3.03	2.74
Receivables	6.16	47.06	5.18	4.97	4.05
Prepaid Expenses	3.04	4.22	1.87	0.75	0.78
Total Current Assets	38.08	61.1	19.65	28.49	39.43
Property, Plant & Equipment	0.74	0.83	0.41	0.53	0.58
Other Intangible Assets	0	-	-	-	0
Other Long-Term Assets	1.24	1.97	5.81	8.18	10.48
Total Assets	40.06	63.91	25.87	37.2	50.49
Accounts Payable	2.32	2.47	2.02	1.91	1.5
Accrued Expenses	3.4	4.94	3.49	2.17	1.1
Current Portion of Long-Term Debt	37.46	13.41	22.28	-	-
Current Portion of Leases	0.12	0.14	0.18	0.17	0.15
Other Current Liabilities	6.83	2.55	0.97	0.79	0.9
Total Current Liabilities	50.13	23.51	28.93	5.04	3.65
Long-Term Debt	-	36.24	25.75	45.17	42.54
Long-Term Leases	0.58	0.67	0.21	0.33	0.39
Pension & Post-Retirement Benefits	0.48	0.46	0.41	0.47	0.58
Other Long-Term Liabilities	-	1.57	0.47	0.22	0.21
Total Liabilities	51.19	62.45	55.77	51.23	47.38
Common Stock	4	3.99	3.57	3.57	3.57
Additional Paid-In Capital	-	-	-	-	5.1
Retained Earnings	-18.27	10.69	-21.4	-22.81	-20.12
Comprehensive Income & Other	3.13	-13.22	-12.08	5.21	14.55
Shareholders' Equity	-11.14	1.46	-29.91	-14.03	3.11
Total Liabilities & Equity	40.06	63.91	25.87	37.2	50.49
Total Debt	38.16	50.47	48.42	45.66	43.08
Net Cash (Debt)	-9.29	-40.64	-35.82	-22.89	-8.49
Net Cash Per Share	-0.47	-1.98	-2.01	-1.28	-0.48
Filing Date Shares Outstanding	20.01	19.96	17.85	17.85	17.85
Total Common Shares Outstanding	20.01	19.96	17.85	17.85	17.85
Working Capital	-12.05	37.6	-9.27	23.45	35.77
Book Value Per Share	-0.56	0.07	-1.68	-0.79	0.17
Tangible Book Value	-11.14	1.46	-29.91	-14.03	3.11
Tangible Book Value Per Share	-0.56	0.07	-1.68	-0.79	0.17

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.